KEGG   DRUG: D02749Help
Entry
D02749                      Drug                                   

Name
Teceleukin (genetical recombination) (JP16);
Teceleukin (USAN);
Imunace (TN)
Formula
C698H1127N179O204S8
Exact mass
15537.1082
Mol weight
15547.0139
Sequence
MAPTSSSTKK TQLQLEHLLL DLQMILNGIN NYKNPKLTRM LTFKFYMPKK ATELKHLQCL
EEELKPLEEV LNLAQSKNFH LRPRDLISNI NVIVLELKGS ETTFMCEYAD ETATIVEFLN
RWITFCQSII STLT (Disulfid bridge: 59-106)
  Type
Peptide
Activity
Immunostimulant [DS:H00021]
Remark
Therapeutic category: 
Comment
recombinant interleukin 2 [HSA:3558] [KO:K05429]
Target
interleukin 2 receptor agonist [HSA:3559 3560 3561] [KO:K05068 K05069 K05070]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04630  Jak-STAT signaling pathway  
 
Interaction
Drug interaction
Brite
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   639  Miscellaneous
    6399  Others
     D02749  Teceleukin (genetical recombination) (JP16); Teceleukin (USAN)
Target-based classification of drugs [BR:br08310]
 Cytokine receptors
  Class I cytokine receptors (hematopoietin family receptors)
   interleukin 2 receptor
    Teceleukin
     D02749  Teceleukin (USAN)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D02749  Teceleukin (genetical recombination)
  D02749  Teceleukin for injection (genetical recombination)
BRITE hierarchy
Other DBs
CAS: 
136279-32-8
PubChem: 

» Japanese version   » Back

DBGET integrated database retrieval system